Insulin Cells WITHOUT Immunosuppressants... Dr. Steve Harr, CEO, Sana Biotechnology
- Author
- Moira Gunn
- Published
- Tue 26 Aug 2025
- Episode Link
- https://share.transistor.fm/s/af5b2c06
This week on BioTech Nation, Dr. Steve Harr, CEO of Sana Biotechnology, talks about their progress in Type I diabetics, in particular. The New England Journal of Medicine publishes early success with Sana Biotechnology's engineered insulin-producing cells without immunosuppressant drugs.
